Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment
Clinical trial NCT03868722 · RECRUITING
Trial details
- NCT number
- NCT03868722
- Sponsor
- Rigshospitalet, Denmark
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2029-07-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.